Evidence map›Paper›PMID 38617967›Full record

ArticleHeliyon2024

Design and preparation of a novel pullulan hard capsule formulation: A promising green candidate and study of crucial capsule features.

Ramin Ramezani Kalmer, Afzal Karimi, Hamed Ramezanalizadeh, Mojgan Ghanbari, Dariush Samandarian, Atefeh Sadjadinia, Samira Gholizadeh Dogaheh, Seyedehmaryam Moosavi

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ramin Ramezani KalmerIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Afzal KarimiIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Hamed RamezanalizadehIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Mojgan GhanbariIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Dariush SamandarianIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Atefeh SadjadiniaIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Samira Gholizadeh DogahehIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.
Seyedehmaryam MoosaviIran Gelatin Capsule mfg Co, 3351773415, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant-based hard capsules have gained considerable attention because of their great properties. Accordingly, designing and developing of these kinds of capsules will be a difficult task. Herein, an innovative pullulan-based hard capsule formulation was prepared for the first time. A series of characterization approaches, including Fourier transform infrared, field emission scanning electron microscope, and rheology analysis, were utilized to figure out the straightforward preparation of a designed hard capsule. Many tests and experiments were performed to achieve the optimum capsule formulation. Based on the obtained results, specifications such as uniform downfall and non-desirable adhesion, and other ideal characteristics of the capsule display the critical function. The gelling promoter of divalent cationic salts is more beneficial than its single-valent counterparts. With respect to the key role of gelling promoter, the presence of chosen MgSO

Indexed as

Gelling agentMoisture contentPlant-based hard capsulesPullulanκ-carrageenan

Identifiers

PMID38617967
PMCPMC11015124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.